US Stock MarketDetailed Quotes

Stoke Therapeutics (STOK)

Watchlist
  • 29.280
  • -1.690-5.46%
Close Jan 15 16:00 ET
1.67BMarket Cap43.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Stoke Therapeutics (STOK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
117.25%10.63M
186.01%13.82M
3,661.12%158.57M
316.34%36.56M
707.07%22.61M
47.94%4.89M
294.72%4.83M
-18.17%4.22M
-29.22%8.78M
-14.26%2.8M
Operating revenue
117.25%10.63M
186.01%13.82M
3,661.12%158.57M
316.34%36.56M
707.07%22.61M
47.94%4.89M
294.72%4.83M
-18.17%4.22M
-29.22%8.78M
-14.26%2.8M
Cost of revenue
Gross profit
Operating expense
53.95%53.72M
20.32%41.12M
45.23%47.33M
11.63%137.93M
11.98%36.27M
14.26%34.9M
11.02%34.17M
9.20%32.59M
5.82%123.55M
6.39%32.39M
Selling and administrative expenses
26.28%16.03M
17.07%15.26M
43.38%14.65M
18.08%48.79M
21.06%12.84M
23.57%12.69M
27.44%13.04M
0.09%10.22M
6.16%41.32M
13.06%10.61M
-General and administrative expense
----
17.07%15.26M
43.38%14.65M
18.08%48.79M
21.06%12.84M
23.57%12.69M
27.44%13.04M
0.09%10.22M
6.16%41.32M
13.06%10.61M
Research and development costs
69.76%37.7M
22.33%25.86M
46.08%32.68M
8.39%89.13M
7.55%23.42M
9.54%22.21M
2.85%21.14M
13.94%22.37M
5.65%82.23M
3.41%21.78M
Operating profit
-43.62%-43.09M
6.96%-27.3M
492.08%111.24M
11.68%-101.37M
53.85%-13.65M
-10.17%-30M
11.79%-29.34M
-14.91%-28.37M
-9.98%-114.77M
-8.87%-29.59M
Net non-operating interest income expense
-2.31%3.46M
2.54%3.79M
19.08%2.89M
27.55%12.64M
14.80%2.97M
33.72%3.55M
43.94%3.7M
15.36%2.43M
217.36%9.91M
74.92%2.59M
Total other finance cost
2.31%-3.46M
-2.54%-3.79M
-19.08%-2.89M
-27.55%-12.64M
-14.80%-2.97M
-33.72%-3.55M
-43.94%-3.7M
-15.36%-2.43M
-217.36%-9.91M
-74.92%-2.59M
Other net income (expense)
-89.29%3K
158.33%28K
106.54%28K
-248.80%-247K
390.24%201K
-31.71%28K
-217.07%-48K
-1,119.05%-428K
-0.60%166K
-2.38%41K
Other non- operating income (expenses)
-89.29%3K
158.33%28K
106.54%28K
-248.80%-247K
390.24%201K
-31.71%28K
-217.07%-48K
-1,119.05%-428K
-0.60%166K
-2.38%41K
Income before tax
-49.92%-39.63M
8.61%-23.48M
532.84%114.16M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
Income tax
-1.28M
0
1.28M
0
0
0
Net income
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
Net income continuous Operations
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
Minority interest income
Net income attributable to the parent company
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
Basic earnings per share
-38.30%-0.65
13.04%-0.4
442.11%1.95
30.67%-1.65
70.00%-0.18
14.55%-0.47
33.33%-0.46
-7.55%-0.57
8.46%-2.38
7.69%-0.6
Diluted earnings per share
-38.30%-0.65
13.04%-0.4
433.33%1.9
30.67%-1.65
70.00%-0.18
14.55%-0.47
33.33%-0.46
-7.55%-0.57
8.46%-2.38
7.69%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 117.25%10.63M186.01%13.82M3,661.12%158.57M316.34%36.56M707.07%22.61M47.94%4.89M294.72%4.83M-18.17%4.22M-29.22%8.78M-14.26%2.8M
Operating revenue 117.25%10.63M186.01%13.82M3,661.12%158.57M316.34%36.56M707.07%22.61M47.94%4.89M294.72%4.83M-18.17%4.22M-29.22%8.78M-14.26%2.8M
Cost of revenue
Gross profit
Operating expense 53.95%53.72M20.32%41.12M45.23%47.33M11.63%137.93M11.98%36.27M14.26%34.9M11.02%34.17M9.20%32.59M5.82%123.55M6.39%32.39M
Selling and administrative expenses 26.28%16.03M17.07%15.26M43.38%14.65M18.08%48.79M21.06%12.84M23.57%12.69M27.44%13.04M0.09%10.22M6.16%41.32M13.06%10.61M
-General and administrative expense ----17.07%15.26M43.38%14.65M18.08%48.79M21.06%12.84M23.57%12.69M27.44%13.04M0.09%10.22M6.16%41.32M13.06%10.61M
Research and development costs 69.76%37.7M22.33%25.86M46.08%32.68M8.39%89.13M7.55%23.42M9.54%22.21M2.85%21.14M13.94%22.37M5.65%82.23M3.41%21.78M
Operating profit -43.62%-43.09M6.96%-27.3M492.08%111.24M11.68%-101.37M53.85%-13.65M-10.17%-30M11.79%-29.34M-14.91%-28.37M-9.98%-114.77M-8.87%-29.59M
Net non-operating interest income expense -2.31%3.46M2.54%3.79M19.08%2.89M27.55%12.64M14.80%2.97M33.72%3.55M43.94%3.7M15.36%2.43M217.36%9.91M74.92%2.59M
Total other finance cost 2.31%-3.46M-2.54%-3.79M-19.08%-2.89M-27.55%-12.64M-14.80%-2.97M-33.72%-3.55M-43.94%-3.7M-15.36%-2.43M-217.36%-9.91M-74.92%-2.59M
Other net income (expense) -89.29%3K158.33%28K106.54%28K-248.80%-247K390.24%201K-31.71%28K-217.07%-48K-1,119.05%-428K-0.60%166K-2.38%41K
Other non- operating income (expenses) -89.29%3K158.33%28K106.54%28K-248.80%-247K390.24%201K-31.71%28K-217.07%-48K-1,119.05%-428K-0.60%166K-2.38%41K
Income before tax -49.92%-39.63M8.61%-23.48M532.84%114.16M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M
Income tax -1.28M01.28M000
Net income -45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M
Net income continuous Operations -45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M
Minority interest income
Net income attributable to the parent company -45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M
Basic earnings per share -38.30%-0.6513.04%-0.4442.11%1.9530.67%-1.6570.00%-0.1814.55%-0.4733.33%-0.46-7.55%-0.578.46%-2.387.69%-0.6
Diluted earnings per share -38.30%-0.6513.04%-0.4433.33%1.930.67%-1.6570.00%-0.1814.55%-0.4733.33%-0.46-7.55%-0.578.46%-2.387.69%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -